KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Position in INCY — Incyte Corp

CIK 1021223 LOS ANGELES, CA

Position in INCY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,833,093

+$527,436 QoQ

Shares Held

24,992

+2.0% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#290

of 849 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $15,557,323 across 9 Biotechnology names. INCY ranks #3 (18.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	12,660	$6,288,601
2	REGN	Regeneron Pharmaceuticals, Inc.	9,223	$5,750,909
3	INCY	Incyte Corp This page	24,992	$2,833,093
4	ONC	BeOne Medicines Ltd.	2,371	$675,663
5	RPRX	Royalty Pharma plc	103	$5,775
6	ALNY	Alnylam Pharmaceuticals, Inc.	7	$2,107
7	IONS	Ionis Pharmaceuticals Inc	7	$555
8	JAZZ	Jazz Pharmaceuticals plc	2	$481

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,833,093	24,992	+2.0%	Shares	Sole	2026-08-13
2026-03-31	$2,305,657	24,497	-8.3%	Shares	Sole	2026-05-14
2025-12-31	$2,637,554	26,704	-18.9%	Shares	Sole	2026-02-13
2025-09-30	$2,793,895	32,943	-18.5%	Shares	Sole	2025-11-13
2025-06-30	$2,753,010	40,426	+30.0%	Shares	Sole	2025-08-13
2025-03-31	$1,883,165	31,101	-13.2%	Shares	Sole	2025-05-14
2024-12-31	$2,476,228	35,851	+7.4%	Shares	Sole	2025-02-21
2024-09-30	$2,206,946	33,388	+13.2%	Shares	Sole	2024-11-13
2024-06-30	$1,787,926	29,494	+413.2%	Shares	Sole	2024-08-13
2024-03-31	$327,406	5,747	+71737.5%	Shares	Sole	2024-05-14
2020-12-31	$695	8	-20.0%	Shares	Sole	2021-02-12
2020-06-30	$1,039	10	0.0%	Shares	Sole	2020-08-14
2020-03-31	$732	10	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.